Notably, type I IFN has been reported to promote CD8+ T-cell expansion (Kolumam et al., 2005), while ISG15+ CD8+ T-cells may represent a promising prognostic biomarker in MDA5+ DM (Ye et al., 2022). The gene discussed is CD8A; the disease is dermatomyositis.